Increased prevalence of ocular glaucomatous abnormalities in systemic sclerosis

Annals of the Rheumatic Diseases

Volumn 63, Issue 10, 2004, Pages 1276-1278

  Allanore, Y ^a,b   Parc, C ^b   Monnet, D ^b   Brezin A P ^b   Kahan, A ^b  

^a Service de Rhumatologie A ^*  (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ARTICLE; AUTOANALYSIS; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; EYE; EYE DISEASE; FEMALE; FOLLOW UP; GLAUCOMA; HUMAN; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MEDICAL EXAMINATION; MEDICAL SPECIALIST; OPHTHALMOSCOPY; OPTIC DISK CUP; OPTIC NERVE DISEASE; OSTEOARTHRITIS; PATHOGENESIS; PATIENT REFERRAL; PERIMETRY; PHOTOGRAPHY; PREVALENCE; PRIORITY JOURNAL; RANK SUM TEST; RETINA; SKIN DISEASE; STATISTICAL ANALYSIS; SYSTEMIC SCLEROSIS; TONOMETRY; VISUAL FIELD DEFECT;

ADULT; AGED; FEMALE; GLAUCOMA; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; OSTEOARTHRITIS; PROSPECTIVE STUDIES; SCLERODERMA, SYSTEMIC; VISUAL ACUITY; VISUAL FIELDS;

EID: 4644308918     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2003.013540     Document Type: Article

References (15)

1. Kahaleh B, Matucci-Cerenic M. Raynaud's phenomenon and scleroderma. Dysregulated neuroendothelial control of vascular tone. Arthritis Rheum 1995;38:1-4.
2. Broadway DC, Drance SM. Glaucoma and vasospasm. Br J Ophthalmol 1998;82:862-70.
3. Quigley HA. Open-angle glaucoma. N Engl J Med 1993;328:1097-106.
4. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, et al. Scleroderma (systemic sclerosis). Classification, subsets and pathogenesis. J Rheumatol 1988;15:202-5.
5. Rodnan GP, Lipinski E, Luksik J. Skin thickness and collagen content in progressive systemic sclerosis and localized scleroderma. Arthritis Rheum 1979;22:130-40.
6. Van Buskirk EM, Cioffi GA. Glaucomatous optic neuropathy. Am J Ophthalmol 1992;113:447-52.
7. Collaborative normal tension glaucoma study group. Natural history of normal tension glaucoma. Ophthalmology 2001;108:247-53.
8. Pradalier A, Hamard P, Sellem E, Bringer L. Migraine and glaucoma: an epidemiologic survey of French ophthalmologists. Cephalalgia 1998;18:74-6.
9. Cartwright MJ, Grajewski AL, Friedberg ML, Anderson DR, Richards DW. Immune-related disease and normal tension glaucoma. A case control study. Arch Ophthalmol 1992;110:500-2.
10. Yamamoto T, Maeda M, Sawada A, Sugiyama K, Taniguchi T, Kitazawa Y, et al. Prevalence of normal-tension glaucoma and primary open-angle glaucoma in patients with collagen diseases. Jpn J Ophthalmol 1999;43:539-42.
11. Wax MB, Tezel G, Saito I, Gupta RS, Harley JB, Li Z, et al. Anti-Ro/SSA positivity and heat shock protein antibodies in patients with normal-pressure glaucoma. Am J Ophthalmol 1998;125:145-57.
12. Hasler PW, Orgül S, Gugleta K, Vogten H, Zhao X, Gherghel D, et al. Vascular dysregulation in the choroid of subjects with acral vasospasm. Arch Ophthalmol 2002;120:302-7.
13. Kahaleh MB. Endothelin, an endothelial-dependent vasoconstrictor in scleroderma. Enhanced production and profibrotic action. Arthritis Rheum 1991;34:978-83.
14. Sugiyama T, Moriya S, Oku H, Azuma I. Association of endothelin-1 with normal tension glaucoma: clinical and fundamental studies. Surv Ophthalmol 1995;39(suppl 1):S49-56.
15. Strenn K, Matulla B, Wolzt M, Findl O, Bekes MC, Lamsfuss U, et al. Reversal of endothelin-1-induced ocular hemodynamic effects by low-dose nifedipine in humans. Clin Pharmacol Ther 1998;63:54-63.